- Roflumilast - Wikipedia
Roflumilast, sold under the brand name Daxas among others, is a medication used for the treatment of chronic obstructive pulmonary disease, [4] plaque psoriasis, [5] seborrheic dermatitis, [6] and atopic dermatitis [5]
- Roflumilast: Uses, Dosage, Side Effects - Drugs. com
Roflumilast (Zoryve) cream is used to treat plaque psoriasis and atopic dermatitis, and roflumilast foam is used for plaque psoriasis and seborrheic dermatitis Includes roflumilast side effects, dose, directions, and indications
- Roflumilast (Daliresp): Uses, Side Effects, Interactions . . . - WebMD
Find patient medical information for Roflumilast (Daliresp) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Roflumilast: MedlinePlus Drug Information
Roflumilast is used in people with severe chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) to reduce the number of episodes or worsening of COPD symptoms Roflumilast is in a class of medications called phosphodiesterase inhibitors It works by decreasing swelling in the lungs
- Roflumilast - Wikiwand
Roflumilast, sold under the brand name Daxas among others, is a medication used for the treatment of chronic obstructive pulmonary disease, [4] plaque psoriasis, [5] seborrheic dermatitis, [6] and atopic dermatitis [5] It acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4) [10] It has anti-inflammatory effects [10][11][12]
- Roflumilast: Uses, Interactions, Mechanism of Action | DrugBank Online
Roflumilast is a selective phosphodiesterase-4 inhibitor indicated to decrease the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) and to treat skin conditions such as plaque psoriasis and atopic dermatitis
- Roflumilast: Uses, Application, and Side-effects — DermNet
Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor used for the treatment of COPD and plaque psoriasis Topical roflumilast 0 3% cream (Zorvye™) was approved by the FDA in 2022 for the treatment of plaque psoriasis in patients aged 12 years and older
- Roflumilast - WikiProjectMed
Roflumilast, sold under the trade name Daxas among others, is a medication used for the long term management of chronic obstructive pulmonary disease (COPD) [1] It is used in those with severe disease [1] It is taken by mouth [1] Common side effects include diarrhea, nausea, headache, back pain, trouble sleeping, and dizziness [2]
|